Milo Gibaldi
#106,539
Most Influential Person Now
Milo Gibaldi's AcademicInfluence.com Rankings
Download Badge
Chemistry
Why Is Milo Gibaldi Influential?
(Suggest an Edit or Addition)Milo Gibaldi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pharmacokinetics, Second Edition (1982) (851)
- Biopharmaceutics and clinical pharmacokinetics (1977) (577)
- Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. (1967) (464)
- Noncompartmental Analysis Based on Statistical Moment Theory (1982) (414)
- Influence of first-pass effect on availability of drugs on oral administration. (1971) (286)
- Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. (1966) (243)
- Increasing Dissolution Rates and Gastrointestinal Absorption of Drugs via solid Solutions and Eutectic mixtures II: Experimental Evaluation of a Eutectic Mixture: Urea-acetaminophen System (1966) (210)
- Relationship Between Drug Concentration in Plasma or Serum and Amount of Drug in the Body (1969) (186)
- Mechanisms of surfactant effects on drug absorption. (1970) (182)
- Drugs and the pharmaceutical sciences (1975) (177)
- The mechanism of the interaction between amiodarone and warfarin in humans (1992) (160)
- Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism (1978) (158)
- The warfarin‐sulfinpyrazone interaction: stereochemical considerations (1986) (156)
- Increasing Dissolution Rates and Gastrointestinal Absorption of Drugs via Solid Solutions and Eutectic mixtures III: Experimental Evaluation of Griseofulvin—succinic Acid Solid Solution (1966) (152)
- Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol--urea system. (1966) (137)
- Predictability of blood levels of gentamicin in man. (1975) (133)
- Clearance and biologic half-life as indices of intrinsic hepatic metabolism. (1974) (131)
- The mechanism of the warfarin‐rifampin drug interaction in humans (1987) (118)
- Solubilizing properties of bile salt solutions. I. Effect of temperature and bile salt concentration on solubilization of glutethimide, griseofulvin, and hexestrol. (1966) (117)
- ADVANCED DRUG DELIVERY (2004) (110)
- New method of solid-state dispersion for increasing dissolution rates. (1966) (109)
- Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects (1977) (101)
- Effects of change in elimination on varous parameters of the two-compartment open model. (1972) (101)
- Characteristics of warfarin hydroxylation catalyzed by human liver microsomes. (1989) (91)
- Endogenous accumulation products and serum protein binding in uremia. (1981) (91)
- Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects (1992) (91)
- Effect of plasma protein and tissue binding on the biologic half‐life of drugs (1978) (81)
- Prediction of Maintenance Dose Required to Attain a Desired Drug Concentration at Steady-state From a Single Determination of Concentration After an Initial Dose (1980) (76)
- Computation of model-independent pharmacokinetic parameters during multiple dosing. (1983) (75)
- Rate of Dissolution of Griseofulvin and Hexoestrol in Bile Salt Solutions (1966) (73)
- General derivation of the equation for time to reach a certain fraction of steady state. (1982) (73)
- Multicompartment pharmacokinetic models and pharmacologic effects. (1969) (70)
- Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. (1977) (70)
- Solubilizing properties of bile salt solutions. II. Effect of inorganic electrolyte, lipids, and a mixed bile salt system on solubilization of glutethimide, griseofulvin, and hexestrol. (1966) (70)
- Drug distribution and pharmacologic effects (1971) (67)
- Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans. (1977) (66)
- Some considerations as to the determination and significance of biologic half-life. (1971) (64)
- Effect of mode of administration on drug distribution in a two-compartment open system. (1969) (61)
- Handbook of clinical pharmacokinetics (1983) (59)
- Pharmacokinetics of digoxin in the rat. (1976) (58)
- Pharmacokinetics in clinical practice. I. Concepts. (1976) (58)
- Estimation of Areas (1982) (58)
- Pharmacokinetics of drug action. (1972) (58)
- ABSORPTION OF DRUGS THROUGH THE ORAL MUCOSA. (1965) (56)
- Kinetics of the Elimination and Neuromuscular Blocking Effect of d-Tubocurarine in Man (1972) (54)
- Interaction of chloramphenicol with phenytoin and phenobarbital; Case report (1978) (52)
- Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution. (1974) (52)
- Metabolic enantiomeric interactions: the inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin. (1991) (51)
- Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve. (1969) (51)
- Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs (2003) (51)
- Route of administration and drug disposition. (1974) (48)
- Effect of an anticholinergic agent on riboflavin absorption in man. (1972) (48)
- Pulmonary Disease and Drug Kinetics (1978) (48)
- Drug elimination and apparent volume of distribution in multicompartment systems. (1972) (47)
- Pharmacokinetic concepts — Drug binding, apparent volume of distribution and clearance (2004) (43)
- Effect of bile salts on gastric emptying and intestinal transit in the rat. (1968) (42)
- Physiologic surface-active agents and drug absorption. I. Effect of sodium taurodeoxycholate on salicylate transfer across the everted rat intestine. (1969) (42)
- Dose-dependent decline of pharmacologic effects of drugs with linear pharmacokinetic characteristics. (1972) (41)
- Bile salt enhancement of riboflavin and flavin mononucleotide absorption in man. (1969) (41)
- Effect of Urea on Solubility: Role of Water Structure (1967) (41)
- Apparent volumes of distribution and drug binding to plasma proteins and tissues (1978) (40)
- Tubocurarine and renal failure. (1972) (39)
- What is Nitric Oxide and Why Are So Many People Studying It? (1993) (39)
- Pharmacokinetics in clinical practice. 2. Applications. (1976) (39)
- Route of administration and drug metabolism. (1972) (38)
- Influence of first-pass effect on the systemic availability of propoxyphene. (1972) (38)
- Introduction to biopharmaceutics (1971) (38)
- Hypothesis for the Individualisation of Drug Dosage (1979) (37)
- Drug distribution in renal failure. (1977) (35)
- Influence of cholestasis on drug elimination: pharmacokinetics. (1976) (35)
- Drug distribution and renal failure. (1972) (34)
- Physiologic surface-active agents and drug absorption. VII. Effect of sodium deoxycholate on phenol red absorption in the rat. (1970) (34)
- Solubilization and rate of dissolution of drugs in the presence of physiologic concentrations of lysolecithin. (1967) (33)
- Prevention and Treatment of Osteoporosis: Does the Future Belong to Hormone Replacement Therapy? (1997) (33)
- Stereoselective and isozyme-selective drug interactions. (1993) (32)
- Tissue binding of drugs. (1977) (32)
- Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease—a hypothesis (1979) (31)
- The effectof route of administration on the metabolic fate of terbutaline in the rat. (1973) (31)
- Biopharmaceutic influences on the anticholinergic effects of propantheline (1975) (30)
- Physiologic surface-active agents and drug absorption. IV. Effect of pre-micellar concentrations of surfactant on dissolution rate. (1969) (30)
- Regulating Angiogenesis: A New Therapeutic Strategy (1998) (30)
- Prediction of systemic availability from plasma‐level data after oral drug administration (1973) (30)
- Screening methods using sulfamethazine for determining acetylator phenotype (1979) (29)
- Effect of plasma protein and tissue binding on the time course of drug concentration in plasma (1979) (29)
- Calculation of absorption rate constants for drugs with incomplete availability. (1973) (29)
- PHARMACOKINETIC ASPECTS OF DRUG METABOLISM (1971) (29)
- Rotating-flask method for dissolution-rate determinations of aspirin from various dosage forms. (1970) (28)
- Intention‐to‐Treat Analysis in Randomized Trials: Who Gets Counted? (1997) (28)
- Physiologic surface-active agents and drug absorption II. Comparison of the effect of sodium taurodeoxycholate and ethylenediaminetetraacetic acid on salicylamide and salicylate transfer across the everted rat small intestine. (1969) (28)
- Pharmacokinetics of Erythromycin on Repetitive Dosing (1977) (28)
- Dissolution rates in surfactant solutions under stirred and static conditions. (1968) (28)
- Enhancement of intestinal absorption of a quaternary ammonium compound by salicylate and trichloroacetate. (1973) (27)
- Dissolution of salicylic acid and polyvinylpyrrolidone from compressed mixtures. (1968) (27)
- Time course and dose dependence of antacid effect on urine pH. (1975) (27)
- Bile Salt-Induced Permeability Changes in the Isolated Rat Intestine 1 (1969) (26)
- Modification of penicillin distribution and elimination by probenecid. (1970) (26)
- Rectal absorption from aspirin suppositories in children and adults. (1974) (26)
- One-Compartment Model (1982) (25)
- Pharmacodynamics of minoxidil as a guide for individualizing dosage regimens in hypertension (1975) (25)
- Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates. (1985) (25)
- Drug transport. 3. Influence of various sugars on passive transfer of several drugs across the everted rat intestine. (1971) (25)
- Drug transport. VI. Functional integrity of the rat everted small intestine with respect to passive transfer. (1972) (24)
- Assessment of drug absorption after oral administration. (1985) (24)
- Fraction unbound in interstitial fluid. (1983) (24)
- DRUG ELIMINATION AND RENAL FUNCTION (1974) (24)
- Estimation of the pharmacokinetic parameters of the two-compartment open model from post-infusion plasma concentration data. (1969) (24)
- Helicobacter pylori and Gastrointestinal Disease (1995) (23)
- Interfacial properties of hydrocarbons (1967) (23)
- Absorption Kinetics and Bioavailability (1982) (23)
- Bioavailability of aspirin from commercial suppositories. (1975) (22)
- Bile salt potentiation of pharmacologic effects and drug uptake in goldfish. (1968) (21)
- Ideal behavior of sodium alkyl sulfates at various interfaces. Thermodynamics of adsorption at the oil-water interface (1968) (21)
- Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding I. Theoretical considerations (2004) (21)
- Hydrodynamic and Diffusional Considerations in Assessing the Effects of Surface Active Agents on the Dissolution Rate of Drugs (1970) (20)
- Effect of sodium deoxycholate on gastric emptying in the rat. (1968) (20)
- Quantitative correlation of absorption and in vitro dissolution kinetics of aspirin from several dosage forms. (1970) (19)
- Method of Residuals (1982) (19)
- Drug Interactions: Part II (1992) (19)
- Use of the overturn end point for the estimation of absorption and elimination kinetics in goldfish. (1968) (19)
- Plasma protein binding of diazepam after a single dose of sodium oleate. (1978) (19)
- Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding II. Physiological significance (2004) (18)
- Plasma protein binding and metabolic clearance of phenytoin in the rat. (1977) (18)
- Drug transport. II. The effect of various cations on the passive transfer of drugs across the everted rat intestine. (1970) (18)
- Kinetics of drug absorption in goldfish. (1971) (18)
- Physiologic surface-active agents and drug absorption. 8. Effect of bile flow on sulfadiazine absorption in the rat. (1971) (18)
- Serum creatinine and drug half-lives in renal failure. (1972) (18)
- Pharmacokinetic model of presystemic metabolism. (1978) (17)
- Pharmacokinetics of bethanidine in hypertensive patients (1975) (17)
- Failure to Comply: A Therapeutic Dilemma and the Bane of Clinical Trials (1996) (17)
- Animal models for investigating intestinal drug absorption: various antibiotics. (1973) (16)
- Pharmacokinetics of Absorption and Elimination of Doxycycline in Man (1967) (16)
- Antioxidant Vitamins and Health (1996) (16)
- Physiologic surface-active agents and drug absorption. 3. Effect of bile salt on drug absorption in goldfish. (1969) (16)
- Evaluation of in vivo drug release by numerical deconvolution using oral solution data as weighting function. (1987) (16)
- Role of surface-active agents in drug absorption. (1970) (15)
- Method for Determining Dissolution Rates of Multiparticulate Systems (1965) (15)
- Compartmental and Noncompartmental Pharmacokinetics 2 14 Gastrointestinal Absorption — Biologic Considerations 24 Gastrointestinal Absorption — Physicochemical Considerations (15)
- Contemporary Use of and Future Roles for Heparin in Antithrombotic Therapy (1995) (14)
- Comparison of observed and predicted bioavailability of nortriptyline in humans following oral administration. (1975) (14)
- The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans (1987) (14)
- Orientation of monolayers of half-esters of poly(methyl vinyl ether maleic anhydride) (1970) (14)
- Estimation of drug elimination in renal failure. (1973) (14)
- Absorption and excretion of riboflavin in the rat: an unusual example of nonlinear pharmacokinetics. (1972) (14)
- Drug Concentrations in the Plasma as an Index of Pharmacologic Effect (1974) (13)
- Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration. (1977) (13)
- Rate-Limiting Barriers in Intestinal Absorption (1972) (13)
- Apparent Volume of Distribution (1982) (13)
- Bioequivalence of thyroid preparations: The final word? (2008) (13)
- Bioavailability of Drugs: Focus on Digoxin (1974) (12)
- Effect of hydrocarbon chain length on adsorption of sodium alkyl sulfates at oil/water interfaces (1968) (11)
- Pharmacogenetics: Part I (2007) (11)
- Biphasic elimination of noscapine. (1966) (11)
- Correlation of pharmacologic activity and dissolution rates of reserpine-desoxycholic acid dispersions. (1968) (11)
- Drug Transport. I. Effect of potassium ion on the in vitro transfer of several drugs across the rat intestine: preliminary observations. (1969) (11)
- Gene and Cell Therapy (2013) (11)
- Individualization of theophylline dosage using a single serum sample following a test dose. (1982) (11)
- Anatomy of an Antibody, and Related Misadventures in Developing an Effective Treatment for Septic Shock (1993) (10)
- Hormone Replacement Therapy: Estrogen After Menopause (1996) (10)
- Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion (1982) (10)
- Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration (1976) (10)
- Monomolecular film properties of protective and enteric film formers. I. Effect of polymer side chain on surface pressure-area isotherms. (1968) (9)
- Revisiting Some Factors Contributing to Variability (1992) (9)
- Effects of First-Pass Metabolism on Metabolite Mean Residence Time Determination After Oral Administration of Parent Drug (2004) (9)
- Some Comments on the Evaluation of Bioavailability Data (1980) (9)
- Tissue distribution kinetics of tetraethylammonium ion in the rat (1980) (9)
- CRITICAL IN VITRO FACTORS IN EVALUATION OF GASTRIC ANTACIDS. II. INHIBITION OF NEUTRALIZATION RATE OF DRIED ALUMINUM HYDROXIDE GEL. (1964) (9)
- Evaluating drug absorption after oral administration. Some problems and some solutions (2004) (9)
- Influence of Pharmacokinetic Diurnal Variation on Bioavailability Estimates (1984) (8)
- Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics (1979) (8)
- Adverse Drug Effect—Reactive Metabolites and Idiosyncratic Drug Reactions: Part I (1992) (8)
- Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosing (1973) (8)
- Estimation of Rates (1982) (8)
- Time-dependent change in renal clearance of bethanidine in humans. (1976) (8)
- Drug transport. V. Mechanism of potassium-ion inhibition of passive transfer of solutes across everted rat intestine. (1971) (8)
- Monomolecular film properties of protective and enteric film formers. II. Evaporation resistance and interactions with plasticizers of poly (methyl vinyl ether-maleic anhydride). (1969) (8)
- ANTIBODIES AND DERIVATIVES (2004) (7)
- The Basic Concept: Clearance (1986) (7)
- Nonlinear pharmacokinetics of indocyanine green in the rabbit and rat (1980) (7)
- Dissolution kinetics in micellar solutions under nonsink conditions. (1969) (7)
- Prediction of Drug Concentrations on Multiple Dosing Using the Principle of Superposition (1982) (7)
- CRITICAL IN VITRO FACTORS IN EVALUATION OF GASTRIC ANTACIDS. I. POLYPEPTIDE INHIBITION. (1963) (7)
- Ethnic Differences in the Assessment and Treatment of Disease (1993) (7)
- Serum levels of penicillins: a pharmacokinetic view. (1968) (6)
- Drug Interactions: Part I (1992) (6)
- Drug transport. IV. Influence of hypotonic and hypertonic solutions on passive drug transfer across the everted rat intestine. (1971) (6)
- Steady-state concentrations of drugs with short half-lives when administered in oral sustained release formulations (1979) (5)
- Single point estimation of phenytoin dosing: a reappraisal. (1981) (5)
- The Eleventh International Conference on AIDS: Cautious Celebration in Vancouver (1997) (5)
- Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate. (1978) (5)
- A model for the prospective identification of the prenephrotoxic state during gentamicin therapy (1978) (5)
- Effect of glucosamine on urinary excretion of salicylate. (1965) (5)
- Pharmacogenetics: Part II (1992) (5)
- Fitting concentration-time data to biexponential equations (1979) (5)
- Biopharmaceutic factors that influence effects of anticholinergic drugs: comparison of propantheline, hexocyclium, and isopropamide. (1977) (5)
- Comparative pharmacokinetics of coumarin anticoaglulants XLI: Effect of phenobarbital on systemic availability of orally administered dicumarol in rats. (1979) (5)
- Single point estimation of phenytoin dosing requirement. (1981) (5)
- Evaluation of the suitability of butadiene-acrylonitrile rubbers as closures for parenteral solutions. (1967) (5)
- Vertical Integration: The Drug Industry and Prescription Benefits Managers (1995) (4)
- Influence of dose on the metabolism and excretion of terbutaline in the rat. (1974) (4)
- Treating Elevated Cholesterol Levels: The Great Satan in Perspective (1996) (4)
- Single point clearance estimation. (1979) (4)
- Are phytoestrogens a "natural alternative" to estrogen replacement therapy? (2000) (4)
- Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity. (1978) (4)
- Estimation of diffusion coefficients and molecular weights of interacting colloids from dissolution-rate data. (1971) (4)
- Pharmacology, Toxicology, Therapeutic Dosage Formulations, and Clinical Response (2004) (3)
- Drug Development and Women: An Overview (1992) (3)
- Use of MULTDOS for pharmacokinetic analysis of ethosuximide data during repetitive administration of single or divided daily doses. (1978) (3)
- The pharmacokinetics of penamecillin. (1966) (3)
- Problem in the estimation of drugs in biologic tissue recovery of phenol red from the GI tract. (1968) (3)
- The effect of body position and pH on the gastrointestinal absorption of salicylate and creatinine in man. (1966) (3)
- Apparent nonsteady-state dissolution phenomenon in solutions of colloidal solubilizers. (1968) (3)
- INTERACTION OF LOW MOLECULAR WEIGHT POLYETHYLENE GLYCOLS WITH SORBITOL SOLUTION. (1964) (3)
- Comparative pharmacokinetics of coumarin anticoagulants. XLII: Effect of phenobarbital on systemic availability of orally administered dicumarol in rats with ligated bile ducts. (1979) (3)
- Ideal gaseous behavior of sodium alkyl sulfates at oil-water interfaces (1967) (3)
- Application of Pharmacokinetic Principles (1982) (3)
- TRANSFORMING PROTEINS AND GENES INTO DRUGS (2013) (2)
- INTRODUCTION TO BIOPHARMACEUTICALS (2004) (2)
- Method for Solving Linear Mammillary Models (1982) (2)
- Pharmacogenetics: Part I (1992) (2)
- Disposition of N,N-bis(phenylcarbamoylmethyl)dimethyl ammonium chloride in the rat: an interesting example of first-pass metabolism. (1975) (2)
- PHARMACOECONOMICS AND DRUG PRICING (2013) (2)
- ADVANCES IN PERSONALIZED MEDICINE: Pharmacogenetics in Drug Therapy (2013) (2)
- Interferons and Cytokines for Anti‐Infective and Cancer Therapy (2004) (2)
- Commentary. Drug distribution and pharmacologic effects. (1971) (2)
- Biopharmaceutical Technologies and Processes in Drug Development (2004) (1)
- Kinetics of Pharmacologic Response (1982) (1)
- Measurement and interpretation of certain biopharmaceutic and pharmacodynamic parameters. (1968) (1)
- Neutralization of aluminum hydroxide dried gel. Citrate and tartrate inhibiton. tartrate inhibition. (1967) (1)
- Biotechnology Industry Perspective on Drug Development (2004) (1)
- CYTOKINES AND INTERFERONS (2013) (1)
- FINANCING BIOLOGIC DRUG DEVELOPMENT (2013) (1)
- Possible error in the use of polynomial approximations in urinary excretion rate studies. (1963) (1)
- Comparative Drug Development of Proteins and Genes versus Small Molecules (2004) (1)
- Adverse Drug Effects: Part II (1992) (1)
- Meta-Analysis (1993) (1)
- Understanding and Treating Some Genetic Diseases (1992) (1)
- LARGE‐SCALE PRODUCTION OF RECOMBINANT PROTEINS (2013) (1)
- Editorial: Bioavailability of drugs: focus on digoxin. (1974) (0)
- Appendix V: Other Information Tables (2004) (0)
- Human Gene Therapy (1993) (0)
- A REPORT ON ALGINIC ACID AS A TABLET DISINTEGRANT (1966) (0)
- Physiological Pharmacokinetlc Models (1982) (0)
- Other Products: Monographs (2004) (0)
- PHARMACOECONOMICS, OUTCOME, AND HEALTH TECHNOLOGY ASSESSMENT RESEARCH IN DRUG DEVELOPMENT (2013) (0)
- Pharmacogenetics: part I: Perspective. 1992. (2007) (0)
- Bile flow in the rat after enteral administration of bile salts (1969) (0)
- Appendix II: Molecular Characteristic and Therapeutic Use (2004) (0)
- CLINICAL EVALUATION AND REGULATORY APPROVAL AND ENFORCEMENT OF BIOPHARMACEUTICALS (2013) (0)
- Vaccination updates. (2000) (0)
- Remembering John G. Wagner (1998) (0)
- Pharmacokinetic Aspects of Nonlinear Drug-Protein Binding (1984) (0)
- Drug Therapy 1999: A Critical Review of Therapeutics (1999) (0)
- Individualization of Drug Regimens: Integration of Pharmacokinetic and Pharmacogenetic Principles in Drug Therapy (2004) (0)
- Hematopoietic Growth Factors and Coagulation Factors (2004) (0)
- Editors & Editorial board (2018) (0)
- Pharmaceutical News Report (2002) (0)
- DISTINCTIONS OF BIOLOGIC VERSUS SMALL MOLECULE PLATFORMS IN DRUG DEVELOPMENT (2013) (0)
- INTEGRATION OF DISCOVERY AND DEVELOPMENT (2013) (0)
- Effect of coadministered salicylamide on terbutaline metabolism in rats. (1977) (0)
- HEMATOPOIETIC GROWTH AND COAGULATION FACTORS (2013) (0)
- The Business of Pharmaceuticals (2002) (0)
- Prescription Drugs and Health Care Reform (1993) (0)
- Method of Laplace Transforms (1982) (0)
- Pharmacokinetic studies of the hypoglycemic effects of insulin in the treatment of diabetic ketoacidosis (1978) (0)
- Estimation of Pharmacokinetic Parameters at Steady-State in Patients (1978) (0)
- Appendix IV: OTHER INFORMATION (2013) (0)
- Reviewers 1991–1994 (2006) (0)
- Integration of Discovery and Development: The Role of Genomics and Proteomics (2004) (0)
- Pharmacogenetics: part II: Perspective. 1992. (2007) (0)
- Will the Nineties Be the Decade We Lost the Battle Against Drug-Resistant Microbes? (1994) (0)
- A COMPENDIUM AND CROSS CORRELATION OF TRADEMARK-GENERIC DESIGNATIONS OF COMMONLY USED DRUGS. II. (1964) (0)
- Bioavailability of Drugs Focus on Digoxin DURING (2005) (0)
- Prevention and Treatment of Stroke: Where Do We Stand? (1997) (0)
- Appendix III: Nomenclature of Biotechnology Products (2004) (0)
- APPLICATION OF BIOTECHNOLOGY IN DRUG DISCOVERY AND EARLY DEVELOPMENT (2013) (0)
- Absorption, metabolism and excretion of N, N-bis(phenylcarbamoylmethyl) dimethylammonium chloride (QX-572) in the rat. (1974) (0)
- Appendix IV: Synonyms of Trade, Common, and Scientific Names (2004) (0)
- SELECTION OF AN OPTIMAL SURFACE FOR THE PREPARATION OF UNIFORM DETACHED FILMS OF ADHESIVE MATERIALS. (1964) (0)
- OTHER BIOPHARMACEUTICAL PRODUCTS (2013) (0)
- Appendix I: Dosage Form, Pharmacokinetics and Disposition Data (2004) (0)
- Drug Therapy, 2000: A Critical Review of Therapeutics (2000) (0)
- Pharmacogenetics: Part II. (2007) (0)
- THERAPEUTIC AND CLINICAL APPLICATIONS OF BIOPHARMACEUTICALS (2013) (0)
- Proceedings: Pharmacokinetic and pharmacodynamic studies with antihypertensive drugs. (1976) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Milo Gibaldi?
Milo Gibaldi is affiliated with the following schools:
